| Contact | Wendy Slatery | FOR IMMEDIATE RELEASE |
| Telephone | 913-742-4456 | October 10, 2017 |
| [email protected] | ||
INNARA HEALTH Receives Innovative Technology Contract from Vizient, Inc.
for NTrainer System
OLATHE, Kan, October 10, 2017– INNARA HEALTH announced its NTRAINER SYSTEM has received an Innovative Technology contract from Vizient, Inc. the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation of NTRAINER SYSTEM by hospital members with expertise in this category who serve on one of Vizient’s member-led councils. Vizient reserves Innovative Technology contracts for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model.
The NTrainer System is the only FDA-cleared solution that provides real-time objective assessment of non-nutritive suck (NNS) as well as consistent, appropriate oral stimulation therapy clinically validated to support the development of NNS skills. Oral feeding is one of the most complex neurodevelopmental skills premature infants must develop and delays in this development can contribute to longer hospitalizations and increased cost of care. Use of the NTrainer System has been attributed to reduced time to achieve full oral feeding competency and reduced length of stay.
“We are proud our NTrainer System has been designated by Vizient as an innovative healthcare technology. To be recognized by the healthcare experts serving on a Vizient advisory council is exceptional and we look forward to working with the full Vizient membership, ” said Michael Peck, president and CEO of Innara Health. “Healthcare is an incredibly dynamic market place that requires careful navigation with multiple contacts within the healthcare system. Through our contact with Vizient, Innara Health can offer savings opportunities to an expanded number of hospital accounts, decrease our time to close new accounts and ensure that we are in the best position to promote an important neonatal feeding technology.”
“Due to the number of products and services being released and marketed as ‘innovative’, member hospitals truly value the thorough innovative technology review process in place at Vizient which helps them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology program for suppliers. “After a full review of the NTrainer System, Vizient’s member council agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology contract. We are pleased to award this new contract to INNARA HEALTH.
Vizient, Inc. represents the combined strengths of the organizations formerly known as VHA Inc., University HealthSystem Consortium, Novation and MedAssets’ Spend and Clinical Resource Management. Since 2003, nearly 2200 new and innovative products and technologies have been submitted through the Vizient Innovative Technology program. Vizient works with member-led councils and task forces to identify and review potentially innovative products. If it is determined that a product is innovative, a contract may be awarded outside of Vizient’s competitive bid cycle.
###
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
Olathe, KAS, Oct. 10, 2017 --


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 



